Circulating exosomal microRNA expression patterns distinguish cardiac sarcoidosis from myocardial ischemia
Open Access
- 26 January 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1) , e0246083
Abstract
Objective: Cardiac sarcoidosis is difficult to diagnose, often requiring expensive and inconvenient advanced imaging techniques. Circulating exosomes contain genetic material, such as microRNA (miRNA), that are derived from diseased tissues and may serve as potential disease-specific biomarkers. We thus sought to determine whether circulating exosome-derived miRNA expression patterns would distinguish cardiac sarcoidosis (CS) from acute myocardial infarction (AMI).Methods: Plasma and serum samples conforming to CS, AMI or disease-free controls were procured from the Biologic Specimen and Data Repository Information Coordinating Center repository and National Jewish Health. Next generation sequencing (NGS) was performed on exosome-derived total RNA (n = 10 for each group), and miRNA expression levels were compared after normalization using housekeeping miRNA. Quality assurance measures excluded poor quality RNA samples. Differentially expressed (DE) miRNA patterns, based upon >2-fold change (p< 0.01), were established in CS compared to controls, and in CS compared to AMI. Relative expression of several DE-miRNA were validated by qRT-PCR.Results: Despite the advanced age of the stored samples (~5–30 years), the quality of the exosome-derived miRNA was intact in ~88% of samples. Comparing plasma exosomal miRNA in CS versus controls, NGS yielded 18 DE transcripts (12 up-regulated, 6 down-regulated), including miRNA previously implicated in mechanisms of myocardial injury (miR-92, miR-21) and immune responses (miR-618, miR-27a). NGS further yielded 52 DE miRNA in serum exosomes from CS versus AMI: 5 up-regulated in CS; 47 up-regulated in AMI, including transcripts previously detected in AMI patients (miR-1-1, miR-133a, miR-208b, miR-423, miR-499). Five miRNAs with increased DE in CS included two isoforms of miR-624 and miR-144, previously reported as markers of cardiomyopathy.Conclusions: MiRNA patterns of exosomes derived from CS and AMI patients are distinct, suggesting that circulating exosomal miRNA patterns could serve as disease biomarkers. Further studies are required to establish their specificity relative to other cardiac disorders.Keywords
Funding Information
- National Institutes of Health (R21HL140012)
- National Institutes of Health (UL1TR002535)
- National Institutes of Health (U01HL112695)
- National Institutes of Health (U01HL112707)
- National Institutes of Health (R01DA040395)
- National Institutes of Health (UG3TR002884)
- U.S. Department of War (W81XWH-16-1-0301)
- U.S. Department of War (W911NF-17-2-0086)
- Foundation for Sarcoidosis Research
This publication has 40 references indexed in Scilit:
- Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial InfarctionMedical Science Monitor, 2019
- Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imagingInternational Journal of Cardiology, 2017
- Circulating microRNAs in patients with ST-elevation myocardial infarctionThe Anatolian Journal of Cardiology, 2015
- Assessment of microRNA differential expression and detection in multiplexed small RNA sequencing dataRNA, 2014
- A case of cardiac sarcoidosis presenting with double tachycardiaJournal of Arrhythmia, 2014
- Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarctionBMC Cardiovascular Disorders, 2013
- Cardiac sarcoidosis mimicking non-ST-elevation myocardial infarctionJournal of Cardiovascular Medicine, 2012
- Methodology for isolation, identification and characterization of microvesicles in peripheral bloodJournal of Immunological Methods, 2012
- The Benjamini-Hochberg Method in the Case of Discrete Test StatisticsThe International Journal of Biostatistics, 2007
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989